OBRENZA 100MG TABLET
Form: Tablets
Pack Size: 60 TABLETS
Marketed by: SUN PHARMA LABORATORIES LTD (ONCOLOGY DIV)
MRP: ₹17690.63
SUN PHARMA LABORATORIES LTD (ONCOLOGY DIV): Obrenza 100MG Tablet, 60 tablets, salt olaparib 100mg. Its MRP stays at Rs 17,690.63 in NPPA's 09-11-2026 anti-cancer trade-margin revision; trade rate Rs 13,478.58. Group: PARP inhibitor (targeted therapy). Same salt is also supplied by Abbott, AstraZeneca, Cipla, Dr. Reddy's, Emcure and others. Handling/counselling: tablet and capsule forms are not interchangeable mg for mg; check the prescription carefully. Schedule H - supply only to licensed buyers and dispense only on prescription.
Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.